End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.91 EUR | +2.36% | +11.40% | -53.57% |
05-15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
04-30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 25.74M 27.91M 2.19B | Sales 2023 | 32.25M 34.97M 2.75B | Capitalization | 25.59M 27.75M 2.18B |
---|---|---|---|---|---|
Net income 2022 | -44M -47.72M -3.75B | Net income 2023 | - 0 0 | EV / Sales 2022 | 3.59 x |
Net cash position 2022 | 4.88M 5.29M 415M | Net cash position 2023 | 1.93M 2.1M 165M | EV / Sales 2023 | 0.73 x |
P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
-40.1
x | Employees | 95 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.4% |
Latest transcript on Biofrontera AG
1 day | +2.36% | ||
1 week | +11.40% | ||
Current month | -46.80% | ||
1 month | -43.23% | ||
3 months | -47.55% | ||
6 months | -61.37% | ||
Current year | -53.57% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 55 | 11/09/22 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 13/12/21 | |
Heikki Lanckriet
BRD | Director/Board Member | 46 | 13/12/21 |
Helge Lubenow
CHM | Chairman | 56 | 13/12/21 |
Date | Price | Change | Volume |
---|---|---|---|
24/05/24 | 3.725 | -4.73% | 1,127 |
23/05/24 | 3.91 | +2.36% | 1,462 |
22/05/24 | 3.82 | +8.22% | 579 |
21/05/24 | 3.53 | +1.73% | 3 |
20/05/24 | 3.47 | -1.14% | 156 |
End-of-day quote Xetra, May 22, 2024
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.57% | 12.28M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- B8FK Stock